| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116fa4406381fc82bb76e8657e68788a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate |
2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_189eddd1100625ffa30072369d8b872b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d2f116cd4c4de0508338506e6297ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65e6ac8c9c056586f63e8e785955bca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dc476b57e70b87cb6f4df102cff4920 |
| publicationDate |
2020-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200131247-A |
| titleOfInvention |
Method for modulating TIGIT and PD-1 signaling pathways using 1,2,4-oxadiazole compounds |
| abstract |
The present invention relates to a method for controlling the TIGIT signaling pathway and the PD-1 signaling pathway. The invention also encompasses the use of a compound of formula (I) or a stereoisomer thereof or a pharmaceutically acceptable salt thereof for the treatment of a disease or disorder mediated by both the TIGIT signaling pathway and the PD-1 signaling pathway. . |
| priorityDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |